Peter Heining
Impact in
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Multiple Sclerosis Research Studies
Papers in
-
- Animal testing and alternatives 3
-
- Sphingolipid Metabolism and Signaling 4
- RNA Interference and Gene Delivery 1
- Lipid Membrane Structure and Behavior 1
- Co-authors
- Gordon Francis (2 shared papers)Pascale Burtin (1 shared paper)Robert Schmouder (1 shared paper)Volker Brinkmann (1 shared paper)Thomas Baumruker (1 shared paper)Shreeram Aradhye (1 shared paper)Andreas Billich (1 shared paper)Hongshan Li (2 shared papers)
- Journals
- Toxicologic Pathology (4 papers)Laboratory Animals (1 paper)Clinica Chimica Acta (1 paper)ACS Medicinal Chemistry Letters (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Peter Heining
12 papers receiving 1.6k citations
Peter Heining's Hit Papers
Peers
Comparison fields: 5 of 103
- Neurology 178
- Pathology and Forensic Medicine 313
- Molecular Biology 1.1k
- Immunology 296
- Cell Biology 183
Countries citing papers authored by Peter Heining
This map shows the geographic impact of Peter Heining's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Heining with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Heining more than expected).
Fields of papers citing papers by Peter Heining
This network shows the impact of papers produced by Peter Heining. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Heining. The network helps show where Peter Heining may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Heining, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Hit paper breakdown → | 2010 | 1082 |
| 2 | 2013 | 145 | |
| 3 | 2014 | 129 | |
| 4 | 2006 | 123 | |
| 5 | 2001 | 63 | |
| 6 | 2000 | 41 | |
| 7 | 2016 | 34 | |
| 8 | 2015 | 27 | |
| 9 | 2002 | 26 | |
| 10 | 2000 | 13 | |
| 11 | 2015 | 13 | |
| 12 | 2015 | 2 |
About Peter Heining
Peter Heining is a scholar working on Small Animals, Molecular Biology, Behavioral Neuroscience, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 1.7k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (4 papers), Animal testing and alternatives (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), RNA Interference and Gene Delivery (1 paper), Cardiovascular Effects of Exercise (1 paper), Pancreatic function and diabetes (1 paper), Xenotransplantation and immune response (1 paper) and Lipid Membrane Structure and Behavior (1 paper). The work is most often cited by research in Neurology (178 citations), Pathology and Forensic Medicine (313 citations), Molecular Biology (1.1k citations), Immunology (296 citations) and Cell Biology (183 citations). Peter Heining has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Gordon Francis, Pascale Burtin, Robert Schmouder, Volker Brinkmann, Thomas Baumruker, Shreeram Aradhye, Andreas Billich, Hongshan Li, William J. Jusko and Guy M. L. Meno‐Tetang. Their work appears in journals such as Toxicologic Pathology, Laboratory Animals, Clinica Chimica Acta, ACS Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.